Urinalysis Market by Product (Dipsticks, Pregnancy & Fertility Kits, Reagents, Disposables, Automated, Semi-automated, POC Analyzers), Application (UTI, Diabetes, Kidney Diseases), End User (Hospitals, Labs, Home Care) & Test Type - Global Forecast to 2027
The global urinalysis market is projected to reach USD 5.7 billion by 2027 from USD 3.9 billion in 2022, at a CAGR of 8.1% during the forecast period. Market growth is driven by factors such as increased production diagnostic products and government initiatives. On the other hand, challenges associated with urinalysis market like changing regulatory landscapes is the major factors hampering the growth of this market.
“The consumables segment accounted for the highest growth rate in the urinalysis market, by product, during the forecast period”
The urinalysis market is segmented into consumables and instruments. In 2021, consumables segment accounted for the highest growth rate in the urinalysis market. Increase in number of research & development and product approval and increased focus on reducing diseases like kidney and liver disease cases which are also associated with age increased age are major factor contributing to the growth of this segment.
“The pregnancy & fertility tests segment accounted for the highest growth in the urinalysis market, by test type, during the forecast period”
The urinalysis market is segmented into pregnancy & fertility tests, biochemical tests and sediment urinalysis. In 2021, pregnancy & fertility tests segment accounted for the highest growth in the urinalysis market. Increasing funds for research, increasing awareness on fertility and pregnancy testing in women and increasing adoption of rapid pregnancy tests is major factor contributing to the growth of this segment.
“The disease screening segment accounted for the highest growth rate in the urinalysis market, by application, during the forecast period”
The urinalysis market is segmented into disease screening and pregnancy & fertility. In 2021, disease screening segment accounted for the highest growth rate in the urinalysis market. Increasing funding for the prevention of diseases like diabetes and Kidney diseases, growth in the number of diagnostic and imaging centers and improving healthcare infrastructure in emerging countries are major factor contributing to the growth of this segment.
“The diagnostic laboratories segment accounted for the highest growth in the urinalysis market, by end user, during the forecast period”
The urinalysis market is segmented into diagnostic laboratories, hospitals & clinics, home care settings and research laboratories and institutes based on end user. In 2021, the diagnostic laboratories segment accounted for the highest growth rate in the urinalysis market. Emerging markets offer lucrative growth opportunities, growing number of regulatory approvals for diagnostic technologies and rising incidence of life style related disorders are major factors contributing to the growth of this segment.
“Asia Pacific: The fastest-growing region in urinalysis market”
The global urinalysis market is segmented into North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa. The Asia Pacific region is projected to register the highest CAGR during the forecast period. Increasing number of conferences focused on creating awareness of diabetes and supportive government policies in the healthcare sector is driving the growth of the urinalysis market in this region.
The primary interviews conducted for this report can be categorized as follows:
This report provides a detailed picture of the global urinalysis market. It aims at estimating the size and future growth potential of the market across different segments, such as product, test type, application, end user and region. The report also includes an in-depth competitive analysis of the key market players, along with their company profiles, recent developments, and key market strategies.
Key Benefits of Buying the Report:
The report will help market leaders/new entrants by providing them with the closest approximations of the revenue numbers for the overall urinalysis market and its subsegments. It will also help stakeholders better understand the competitive landscape and gain more insights to better position their business and make suitable go-to-market strategies. This report will enable stakeholders to understand the market's pulse and provide them with information on the key market drivers, restraints, opportunities and challenges.
“The consumables segment accounted for the highest growth rate in the urinalysis market, by product, during the forecast period”
The urinalysis market is segmented into consumables and instruments. In 2021, consumables segment accounted for the highest growth rate in the urinalysis market. Increase in number of research & development and product approval and increased focus on reducing diseases like kidney and liver disease cases which are also associated with age increased age are major factor contributing to the growth of this segment.
“The pregnancy & fertility tests segment accounted for the highest growth in the urinalysis market, by test type, during the forecast period”
The urinalysis market is segmented into pregnancy & fertility tests, biochemical tests and sediment urinalysis. In 2021, pregnancy & fertility tests segment accounted for the highest growth in the urinalysis market. Increasing funds for research, increasing awareness on fertility and pregnancy testing in women and increasing adoption of rapid pregnancy tests is major factor contributing to the growth of this segment.
“The disease screening segment accounted for the highest growth rate in the urinalysis market, by application, during the forecast period”
The urinalysis market is segmented into disease screening and pregnancy & fertility. In 2021, disease screening segment accounted for the highest growth rate in the urinalysis market. Increasing funding for the prevention of diseases like diabetes and Kidney diseases, growth in the number of diagnostic and imaging centers and improving healthcare infrastructure in emerging countries are major factor contributing to the growth of this segment.
“The diagnostic laboratories segment accounted for the highest growth in the urinalysis market, by end user, during the forecast period”
The urinalysis market is segmented into diagnostic laboratories, hospitals & clinics, home care settings and research laboratories and institutes based on end user. In 2021, the diagnostic laboratories segment accounted for the highest growth rate in the urinalysis market. Emerging markets offer lucrative growth opportunities, growing number of regulatory approvals for diagnostic technologies and rising incidence of life style related disorders are major factors contributing to the growth of this segment.
“Asia Pacific: The fastest-growing region in urinalysis market”
The global urinalysis market is segmented into North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa. The Asia Pacific region is projected to register the highest CAGR during the forecast period. Increasing number of conferences focused on creating awareness of diabetes and supportive government policies in the healthcare sector is driving the growth of the urinalysis market in this region.
The primary interviews conducted for this report can be categorized as follows:
- By Company Type: Tier 1 - 40%, Tier 2 - 30%, and Tier 3 - 30%
- By Designation: C-level - 27%, D-level - 18%, and Others - 55%
- By Region: North America - 51%, Europe - 21%, Asia Pacific - 18%, Latin America – 6% , and the Middle East & Africa – 4%
- Siemens Healthineers AG (Germany)
- F. Hoffmann-La Roche Ltd. (Switzerland)
- Cardinal Health, Inc. (US)
- Abbott Laboratories (US)
- Danaher Corporation (US)
- Sysmex Corporation (Japan)
- Thermo Fisher Scientific, Inc. (US)
- Quidel Corporation (US)
- Becton, Dickinson and Company (US)
- Bio-Rad Laboratories, Inc. (US)
- EKF Diagnostics (UK)
This report provides a detailed picture of the global urinalysis market. It aims at estimating the size and future growth potential of the market across different segments, such as product, test type, application, end user and region. The report also includes an in-depth competitive analysis of the key market players, along with their company profiles, recent developments, and key market strategies.
Key Benefits of Buying the Report:
The report will help market leaders/new entrants by providing them with the closest approximations of the revenue numbers for the overall urinalysis market and its subsegments. It will also help stakeholders better understand the competitive landscape and gain more insights to better position their business and make suitable go-to-market strategies. This report will enable stakeholders to understand the market's pulse and provide them with information on the key market drivers, restraints, opportunities and challenges.
1 INTRODUCTION
1.1 STUDY OBJECTIVES
1.2 MARKET DEFINITION
1.2.1 INCLUSIONS AND EXCLUSIONS
1.3 MARKETS COVERED
1.3.1 URINALYSIS MARKET SEGMENTATION
1.3.2 REGIONAL SCOPE
1.3.3 YEARS CONSIDERED
1.4 CURRENCY CONSIDERED
1.5 LIMITATIONS
1.6 STAKEHOLDERS
1.7 SUMMARY OF CHANGES
2 RESEARCH METHODOLOGY
2.1 RESEARCH DATA
2.2 RESEARCH APPROACH
FIGURE 1 URINALYSIS MARKET: RESEARCH DESIGN
2.2.1 SECONDARY DATA
2.2.1.1 Key data from secondary sources
2.2.1.2 Activities involved in secondary research
2.2.2 PRIMARY DATA
2.2.2.1 Primary sources
2.2.2.2 Key data from primary sources
2.2.2.3 Key industry insights
2.2.2.4 Breakdown of primary interviews
FIGURE 2 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE AND DEMAND-SIDE PARTICIPANTS
FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
2.3 MARKET SIZE ESTIMATION
2.3.1 BOTTOM-UP APPROACH
2.3.1.1 Approach 1: Company revenue estimation
FIGURE 4 BOTTOM-UP APPROACH: COMPANY REVENUE ESTIMATION APPROACH
2.3.1.2 Approach 2: Company presentations and primary interviews
2.3.1.3 CAGR projections
FIGURE 5 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS
2.3.2 TOP-DOWN APPROACH
FIGURE 6 URINALYSIS MARKET: TOP-DOWN APPROACH
2.4 DATA TRIANGULATION
FIGURE 7 DATA TRIANGULATION METHODOLOGY
2.5 MARKET SHARE ANALYSIS
2.6 STUDY ASSUMPTIONS
2.7 GROWTH RATE ASSUMPTIONS
2.8 RISK ASSESSMENT
2.8.1 RISK ASSESSMENT: URINALYSIS MARKET
2.9 RECESSION IMPACT
3 EXECUTIVE SUMMARY
FIGURE 8 URINALYSIS MARKET, BY PRODUCT, 2022 VS. 2027 (USD MILLION)
FIGURE 9 URINALYSIS MARKET, BY TEST TYPE, 2022 VS. 2027 (USD MILLION)
FIGURE 10 URINALYSIS MARKET, BY APPLICATION, 2022 VS. 2027 (USD MILLION)
FIGURE 11 URINALYSIS MARKET, BY END USER, 2022 VS. 2027 (USD MILLION)
FIGURE 12 URINALYSIS MARKET, BY REGION, 2022 VS. 2027 (USD MILLION)
4 PREMIUM INSIGHTS
4.1 URINALYSIS MARKET OVERVIEW
FIGURE 13 RISING ADOPTION OF POC DIAGNOSTICS TO SUPPORT MARKET GROWTH DURING FORECAST PERIOD
4.2 URINALYSIS MARKET SHARE, BY PRODUCT, 2022 VS. 2027
FIGURE 14 CONSUMABLES SEGMENT TO DOMINATE MARKET DURING FORECAST PERIOD
4.3 URINALYSIS MARKET SHARE, BY TEST TYPE, 2022 VS. 2027
FIGURE 15 BIOCHEMICAL URINALYSIS TO HOLD LARGEST MARKET SHARE DURING FORECAST PERIOD
4.4 URINALYSIS MARKET SHARE, BY APPLICATION, 2022 VS. 2027
FIGURE 16 DISEASE SCREENING SEGMENT TO LEAD MARKET DURING FORECAST PERIOD
4.5 URINALYSIS MARKET SHARE, BY END USER, 2022 VS. 2027
FIGURE 17 DIAGNOSTICS LABORATORIES TO ACCOUNT FOR DOMINANT MARKET SHARE DURING FORECAST PERIOD
4.6 URINALYSIS MARKET: REGIONAL GROWTH OPPORTUNITIES
FIGURE 18 ASIA PACIFIC TO REGISTER HIGHEST GROWTH RATE DURING FORECAST PERIOD
5 MARKET OVERVIEW
5.1 INTRODUCTION
5.2 MARKET DYNAMICS
FIGURE 19 URINALYSIS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
5.2.1 DRIVERS
5.2.1.1 Increasing burden of UTIs, diabetes, and liver & kidney diseases to impact market
5.2.1.2 Rising geriatric population and age-associated diseases to fuel market growth
TABLE 1 ESTIMATED INCREASE IN GERIATRIC POPULATION, BY REGION (2019–2050)
5.2.1.3 Increasing adoption of POC urine diagnostic tests to drive market
5.2.2 RESTRAINTS
5.2.2.1 Availability of refurbished urine analyzers to pose challenges for market
5.2.2.2 High capital investments and lack of skilled laboratory technicians to restrain market growth
5.2.3 OPPORTUNITIES
5.2.3.1 Increasing investments in healthcare and life sciences to fuel growth in emerging markets
5.2.3.2 Technological advancements in urine analyzers to augment market growth
5.2.3.3 Increasing government initiatives and funding for preventive care to provide growth opportunities
5.2.4 CHALLENGES
5.2.4.1 Changing regulatory landscape to challenge market growth
6 URINALYSIS MARKET, BY PRODUCT
6.1 INTRODUCTION
TABLE 2 URINALYSIS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
6.2 CONSUMABLES
TABLE 3 URINALYSIS MARKET FOR CONSUMABLES, BY TYPE, 2020–2027 (USD MILLION)
TABLE 4 URINALYSIS MARKET FOR CONSUMABLES, BY REGION, 2020–2027 (USD MILLION)
6.2.1 PREGNANCY & FERTILITY KITS
6.2.1.1 Rapid accessibility and testing convenience to drive market
TABLE 5 URINALYSIS MARKET FOR PREGNANCY & FERTILITY KITS, BY REGION, 2020–2027 (USD MILLION)
6.2.2 DIPSTICKS
6.2.2.1 Low cost and standard efficiency to increase use of dipsticks
TABLE 6 URINALYSIS MARKET FOR DIPSTICKS, BY REGION, 2020–2027 (USD MILLION)
6.2.3 DISPOSABLES
6.2.3.1 Urine collection cups to drive demand for disposables
TABLE 7 URINALYSIS MARKET FOR DISPOSABLES, BY REGION, 2020–2027 (USD MILLION)
6.2.4 REAGENTS
6.2.4.1 Increasing use of controls and calibrators to drive market growth
TABLE 8 URINALYSIS MARKET FOR REAGENTS, BY REGION, 2020–2027 (USD MILLION)
6.3 INSTRUMENTS
TABLE 9 KEY PRODUCTS IN INSTRUMENTS SEGMENT
TABLE 10 URINALYSIS MARKET FOR INSTRUMENTS, BY TYPE, 2020–2027 (USD MILLION)
TABLE 11 URINALYSIS MARKET FOR INSTRUMENTS, BY REGION, 2020–2027 (USD MILLION)
6.3.1 AUTOMATED URINE ANALYZERS
TABLE 12 URINALYSIS MARKET FOR AUTOMATED URINE ANALYZERS, BY TYPE, 2020–2027 (USD MILLION)
TABLE 13 URINALYSIS MARKET FOR AUTOMATED URINE ANALYZERS, BY REGION, 2020–2027 (USD MILLION)
6.3.1.1 Integrated urine analyzers
6.3.1.1.1 Higher workload in hospitals and laboratories to increase adoption of integrated urine analyzers
TABLE 14 URINALYSIS MARKET FOR INTEGRATED URINE ANALYZERS, BY REGION, 2020–2027 (USD MILLION)
6.3.1.2 Sediment urine analyzers
TABLE 15 URINALYSIS MARKET FOR SEDIMENT URINE ANALYZERS, BY TYPE, 2020–2027 (USD MILLION)
TABLE 16 URINALYSIS MARKET FOR SEDIMENT URINE ANALYZERS, BY REGION, 2020–2027 (USD MILLION)
6.3.1.2.1 Microscopy analyzers
6.3.1.2.1.1 Increased adoption of automated microscopy urine analyzers to drive market growth
TABLE 17 URINALYSIS MARKET FOR MICROSCOPY ANALYZERS, BY REGION, 2020–2027 (USD MILLION)
6.3.1.2.2 Flow cytometry analyzers
6.3.1.2.2.1 Accuracy and sensitivity of flow cytometry analyzers to drive adoption
TABLE 18 URINALYSIS MARKET FOR FLOW CYTOMETRY ANALYZERS, BY REGION, 2020–2027 (USD MILLION)
6.3.1.3 Biochemical urine analyzers
6.3.1.3.1 Increasing incidence of kidney diseases and UTIs to drive market
TABLE 19 URINALYSIS MARKET FOR BIOCHEMICAL URINE ANALYZERS, BY REGION, 2020–2027 (USD MILLION)
6.3.2 SEMI-AUTOMATED URINE ANALYZERS
6.3.2.1 Extensive use of semi-automated urine analyzers in hospitals & clinics to drive segment growth
TABLE 20 URINALYSIS MARKET FOR SEMI-AUTOMATED URINE ANALYZERS, BY REGION, 2020–2027 (USD MILLION)
6.3.3 POINT-OF-CARE URINE ANALYZERS
6.3.3.1 Need for rapid testing to drive demand for POC urine analyzers
TABLE 21 URINALYSIS MARKET FOR POC URINE ANALYZERS, BY REGION, 2020–2027 (USD MILLION)
7 URINALYSIS MARKET, BY TEST TYPE
7.1 INTRODUCTION
TABLE 22 URINALYSIS MARKET, BY TEST TYPE, 2020–2027 (USD MILLION)
7.2 PREGNANCY & FERTILITY TESTS
7.2.1 RISING DEMAND FOR RAPID SELF-CONTAINED TESTS TO DRIVE SEGMENT GROWTH
TABLE 23 URINALYSIS MARKET FOR PREGNANCY & FERTILITY TESTS, BY REGION, 2020–2027 (USD MILLION)
7.3 BIOCHEMICAL TESTS
TABLE 24 URINALYSIS MARKET FOR BIOCHEMICAL TESTS, BY TYPE, 2020–2027 (USD MILLION)
TABLE 25 URINALYSIS MARKET FOR BIOCHEMICAL TESTS, BY REGION, 2020–2027 (USD MILLION)
7.3.1 LABORATORY TESTS
7.3.1.1 Growing incidence of UTIs and other kidney diseases to drive market
TABLE 26 URINALYSIS MARKET FOR LABORATORY TESTS, BY REGION, 2020–2027 (USD MILLION)
7.3.2 POC TESTS
7.3.2.1 Convenience of POC testing to drive segment growth
TABLE 27 URINALYSIS MARKET FOR POC TESTS, BY REGION, 2020–2027 (USD MILLION)
7.4 SEDIMENT URINALYSIS
7.4.1 INCREASED ADOPTION OF AUTOMATED ANALYZERS TO DRIVE MARKET GROWTH
TABLE 28 URINALYSIS MARKET FOR SEDIMENT URINALYSIS, BY TYPE, 2020–2027 (USD MILLION)
8 URINALYSIS MARKET, BY APPLICATION
8.1 INTRODUCTION
TABLE 29 URINALYSIS MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
8.2 DISEASE SCREENING
TABLE 30 URINALYSIS MARKET FOR DISEASE SCREENING, BY TYPE, 2020–2027 (USD MILLION)
TABLE 31 URINALYSIS MARKET FOR DISEASE SCREENING, BY REGION, 2020–2027 (USD MILLION)
8.2.1 URINARY TRACT INFECTIONS
8.2.1.1 Increasing prevalence of UTIs to drive segment growth
TABLE 32 URINALYSIS MARKET FOR URINARY TRACT INFECTIONS, BY REGION, 2020–2027 (USD MILLION)
8.2.2 KIDNEY DISEASES
8.2.2.1 Rapidly growing geriatric population and prevalence of kidney diseases to fuel segment growth
TABLE 33 URINALYSIS MARKET FOR KIDNEY DISEASES, BY REGION, 2020–2027 (USD MILLION)
8.2.3 DIABETES
8.2.3.1 Development of advanced analytical tools for diabetes to drive market growth
TABLE 34 URINALYSIS MARKET FOR DIABETES, BY REGION, 2020–2027 (USD MILLION)
8.2.4 LIVER DISEASES
8.2.4.1 High prevalence of liver diseases to fuel segment growth
TABLE 35 URINALYSIS MARKET FOR LIVER DISEASES, BY REGION, 2020–2027 (USD MILLION)
8.2.5 OTHER DISEASE SCREENING APPLICATIONS
TABLE 36 URINALYSIS MARKET FOR OTHER DISEASE SCREENING APPLICATIONS, BY REGION, 2020–2027 (USD MILLION)
8.3 PREGNANCY & FERTILITY
8.3.1 NEED FOR EARLY DETECTION OF PREGNANCY TO DRIVE SEGMENT
TABLE 37 URINALYSIS MARKET FOR PREGNANCY & FERTILITY, BY REGION, 2020–2027 (USD MILLION)
9 URINALYSIS MARKET, BY END USER
9.1 INTRODUCTION
TABLE 38 URINALYSIS MARKET, BY END USER, 2020–2027 (USD MILLION)
9.2 DIAGNOSTIC LABORATORIES
9.2.1 INCREASED OUTSOURCING OF DIAGNOSTIC TESTS BY HOSPITALS TO LABORATORIES TO AUGMENT MARKET
TABLE 39 URINALYSIS MARKET FOR DIAGNOSTIC LABORATORIES, BY REGION, 2020–2027 (USD MILLION)
9.3 HOSPITALS & CLINICS
9.3.1 INCREASING ADOPTION OF DIAGNOSTIC TOOLS FOR URINALYSIS TESTING TO DRIVE MARKET
TABLE 40 URINALYSIS MARKET FOR HOSPITALS & CLINICS, BY REGION, 2020–2027 (USD MILLION)
9.4 HOME CARE SETTINGS
9.4.1 INCREASING PREFERENCE FOR RAPID TESTING AND CONVENIENCE TO BOOST MARKET
TABLE 41 URINALYSIS MARKET FOR HOME CARE SETTINGS, BY REGION, 2020–2027 (USD MILLION)
9.5 RESEARCH LABORATORIES & INSTITUTES
9.5.1 DEVELOPING INNOVATIVE TESTS FOR DISEASE DETECTION TO FUEL MARKET
TABLE 42 URINALYSIS MARKET FOR RESEARCH LABORATORIES & INSTITUTES, BY REGION, 2020–2027 (USD MILLION)
10 URINALYSIS MARKET, BY REGION
10.1 INTRODUCTION
TABLE 43 URINALYSIS MARKET, BY REGION, 2020–2027 (USD MILLION)
10.2 NORTH AMERICA
FIGURE 20 NORTH AMERICA: URINALYSIS MARKET SNAPSHOT
TABLE 44 NORTH AMERICA: URINALYSIS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 45 NORTH AMERICA: URINALYSIS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 46 NORTH AMERICA: CONSUMABLES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 47 NORTH AMERICA: INSTRUMENTS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 48 NORTH AMERICA: AUTOMATED URINE ANALYZERS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 49 NORTH AMERICA: SEDIMENT URINE ANALYZERS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 50 NORTH AMERICA: URINALYSIS MARKET, BY TEST TYPE, 2020–2027 (USD MILLION)
TABLE 51 NORTH AMERICA: BIOCHEMICAL TESTS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 52 NORTH AMERICA: URINALYSIS MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 53 NORTH AMERICA: DISEASE SCREENING MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 54 NORTH AMERICA: URINALYSIS MARKET, BY END USER, 2020–2027 (USD MILLION)
10.2.1 RECESSION IMPACT
10.2.2 US
10.2.2.1 Rapid growth of geriatric population to drive market growth
TABLE 55 US: URINALYSIS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 56 US: CONSUMABLES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 57 US: INSTRUMENTS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 58 US: AUTOMATED URINE ANALYZERS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 59 US: SEDIMENT URINE ANALYZERS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 60 US: URINALYSIS MARKET, BY TEST TYPE, 2020–2027 (USD MILLION)
TABLE 61 US: BIOCHEMICAL TESTS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 62 US: URINALYSIS MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 63 US: DISEASE SCREENING MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 64 US: URINALYSIS MARKET, BY END USER, 2020–2027 (USD MILLION)
10.2.3 CANADA
10.2.3.1 Increasing prevalence of chronic diseases to augment market
TABLE 65 CANADA: URINALYSIS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 66 CANADA: CONSUMABLES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 67 CANADA: INSTRUMENTS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 68 CANADA: AUTOMATED URINE ANALYZERS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 69 CANADA: SEDIMENT URINE ANALYZERS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 70 CANADA: URINALYSIS MARKET, BY TEST TYPE, 2020–2027 (USD MILLION)
TABLE 71 CANADA: BIOCHEMICAL TESTS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 72 CANADA: URINALYSIS MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 73 CANADA: DISEASE SCREENING MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 74 CANADA: URINALYSIS MARKET, BY END USER, 2020–2027 (USD MILLION)
10.3 EUROPE
TABLE 75 EUROPE: URINALYSIS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 76 EUROPE: URINALYSIS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 77 EUROPE: CONSUMABLES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 78 EUROPE: INSTRUMENTS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 79 EUROPE: AUTOMATED URINE ANALYZERS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 80 EUROPE: SEDIMENT URINE ANALYZERS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 81 EUROPE: URINALYSIS MARKET, BY TEST TYPE, 2020–2027 (USD MILLION)
TABLE 82 EUROPE: BIOCHEMICAL TESTS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 83 EUROPE: URINALYSIS MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 84 EUROPE: DISEASE SCREENING MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 85 EUROPE: URINALYSIS MARKET, BY END USER, 2020–2027 (USD MILLION)
10.3.1 RECESSION IMPACT
10.3.2 GERMANY
10.3.2.1 Increasing healthcare expenditure to fuel market growth
TABLE 86 GERMANY: URINALYSIS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 87 GERMANY: CONSUMABLES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 88 GERMANY: INSTRUMENTS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 89 GERMANY: AUTOMATED URINE ANALYZERS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 90 GERMANY: SEDIMENT URINE ANALYZERS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 91 GERMANY: URINALYSIS MARKET, BY TEST TYPE, 2020–2027 (USD MILLION)
TABLE 92 GERMANY: BIOCHEMICAL TESTS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 93 GERMANY: URINALYSIS MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 94 GERMANY: DISEASE SCREENING MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 95 GERMANY: URINALYSIS MARKET, BY END USER, 2020–2027 (USD MILLION)
10.3.3 UK
10.3.3.1 Rising government healthcare expenditure to propel market growth
TABLE 96 UK: URINALYSIS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 97 UK: CONSUMABLES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 98 UK: INSTRUMENTS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 99 UK: AUTOMATED URINE ANALYZERS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 100 UK: SEDIMENT URINE ANALYZERS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 101 UK: URINALYSIS MARKET, BY TEST TYPE, 2020–2027 (USD MILLION)
TABLE 102 UK: BIOCHEMICAL TESTS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 103 UK: URINALYSIS MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 104 UK: DISEASE SCREENING MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 105 UK: URINALYSIS MARKET, BY END USER, 2020–2027 (USD MILLION)
10.3.4 FRANCE
10.3.4.1 High R&D expenditure to provide growth opportunities
TABLE 106 FRANCE: URINALYSIS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 107 FRANCE: CONSUMABLES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 108 FRANCE: INSTRUMENTS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 109 FRANCE: AUTOMATED URINE ANALYZERS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 110 FRANCE: SEDIMENT URINE ANALYZERS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 111 FRANCE: URINALYSIS MARKET, BY TEST TYPE, 2020–2027 (USD MILLION)
TABLE 112 FRANCE: BIOCHEMICAL TESTS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 113 FRANCE: URINALYSIS MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 114 FRANCE: DISEASE SCREENING MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 115 FRANCE: URINALYSIS MARKET, BY END USER, 2020–2027 (USD MILLION)
10.3.5 ITALY
10.3.5.1 Large aging population to drive market growth
TABLE 116 ITALY: URINALYSIS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 117 ITALY: CONSUMABLES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 118 ITALY: INSTRUMENTS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 119 ITALY: AUTOMATED URINE ANALYZERS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 120 ITALY: SEDIMENT URINE ANALYZERS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 121 ITALY: URINALYSIS MARKET, BY TEST TYPE, 2020–2027 (USD MILLION)
TABLE 122 ITALY: BIOCHEMICAL TESTS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 123 ITALY: URINALYSIS MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 124 ITALY: DISEASE SCREENING MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 125 ITALY: URINALYSIS MARKET, BY END USER, 2020–2027 (USD MILLION)
10.3.6 SPAIN
10.3.6.1 Rising geriatric population to propel market
TABLE 126 SPAIN: URINALYSIS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 127 SPAIN: CONSUMABLES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 128 SPAIN: INSTRUMENTS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 129 SPAIN: AUTOMATED URINE ANALYZERS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 130 SPAIN: SEDIMENT URINE ANALYZERS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 131 SPAIN: URINALYSIS MARKET, BY TEST TYPE, 2020–2027 (USD MILLION)
TABLE 132 SPAIN: BIOCHEMICAL TESTS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 133 SPAIN: URINALYSIS MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 134 SPAIN: DISEASE SCREENING MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 135 SPAIN: URINALYSIS MARKET, BY END USER, 2020–2027 (USD MILLION)
10.3.7 REST OF EUROPE
TABLE 136 REST OF EUROPE: URINALYSIS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 137 REST OF EUROPE: CONSUMABLES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 138 REST OF EUROPE: INSTRUMENTS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 139 REST OF EUROPE: AUTOMATED URINE ANALYZERS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 140 REST OF EUROPE: SEDIMENT URINE ANALYZERS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 141 REST OF EUROPE: URINALYSIS MARKET, BY TEST TYPE, 2020–2027 (USD MILLION)
TABLE 142 REST OF EUROPE: BIOCHEMICAL TESTS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 143 REST OF EUROPE: URINALYSIS MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 144 REST OF EUROPE: DISEASE SCREENING MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 145 REST OF EUROPE: URINALYSIS MARKET, BY END USER, 2020–2027 (USD MILLION)
10.4 ASIA PACIFIC
FIGURE 21 ASIA PACIFIC: URINALYSIS MARKET SNAPSHOT
TABLE 146 ASIA PACIFIC: URINALYSIS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 147 ASIA PACIFIC: URINALYSIS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 148 ASIA PACIFIC: CONSUMABLES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 149 ASIA PACIFIC: INSTRUMENTS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 150 ASIA PACIFIC: AUTOMATED URINE ANALYZERS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 151 ASIA PACIFIC: SEDIMENT URINE ANALYZERS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 152 ASIA PACIFIC: URINALYSIS MARKET, BY TEST TYPE, 2020–2027 (USD MILLION)
TABLE 153 ASIA PACIFIC: BIOCHEMICAL TESTS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 154 ASIA PACIFIC: URINALYSIS MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 155 ASIA PACIFIC: DISEASE SCREENING MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 156 ASIA PACIFIC: URINALYSIS MARKET, BY END USER, 2020–2027 (USD MILLION)
10.4.1 RECESSION IMPACT
10.4.2 CHINA
10.4.2.1 Improving healthcare infrastructure in China to support market growth
TABLE 157 CHINA: URINALYSIS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 158 CHINA: CONSUMABLES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 159 CHINA: INSTRUMENTS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 160 CHINA: AUTOMATED URINE ANALYZERS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 161 CHINA: SEDIMENT URINE ANALYZERS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 162 CHINA: URINALYSIS MARKET, BY TEST TYPE, 2020–2027 (USD MILLION)
TABLE 163 CHINA: BIOCHEMICAL TESTS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 164 CHINA: URINALYSIS MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 165 CHINA: DISEASE SCREENING MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 166 CHINA: URINALYSIS MARKET, BY END USER, 2020–2027 (USD MILLION)
10.4.3 JAPAN
10.4.3.1 Favorable regulatory framework to drive market growth
TABLE 167 JAPAN: URINALYSIS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 168 JAPAN: CONSUMABLES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 169 JAPAN: INSTRUMENTS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 170 JAPAN: AUTOMATED URINE ANALYZERS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 171 JAPAN: SEDIMENT URINE ANALYZERS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 172 JAPAN: URINALYSIS MARKET, BY TEST TYPE, 2020–2027 (USD MILLION)
TABLE 173 JAPAN: BIOCHEMICAL TESTS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 174 JAPAN: URINALYSIS MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 175 JAPAN: DISEASE SCREENING MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 176 JAPAN: URINALYSIS MARKET, BY END USER, 2020–2027 (USD MILLION)
10.4.4 INDIA
10.4.4.1 Increasing investment in India’s healthcare system to drive market
TABLE 177 INDIA: URINALYSIS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 178 INDIA: CONSUMABLES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 179 INDIA: INSTRUMENTS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 180 INDIA: AUTOMATED URINE ANALYZERS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 181 INDIA: SEDIMENT URINE ANALYZERS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 182 INDIA: URINALYSIS MARKET, BY TEST TYPE, 2020–2027 (USD MILLION)
TABLE 183 INDIA: BIOCHEMICAL TESTS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 184 INDIA: URINALYSIS MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 185 INDIA: DISEASE SCREENING MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 186 INDIA: URINALYSIS MARKET, BY END USER, 2020–2027 (USD MILLION)
10.4.5 REST OF ASIA PACIFIC
TABLE 187 REST OF ASIA PACIFIC: URINALYSIS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 188 REST OF ASIA PACIFIC: CONSUMABLES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 189 REST OF ASIA PACIFIC: INSTRUMENTS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 190 REST OF ASIA PACIFIC: AUTOMATED URINE ANALYZERS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 191 REST OF ASIA PACIFIC: SEDIMENT URINE ANALYZERS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 192 REST OF ASIA PACIFIC: URINALYSIS MARKET, BY TEST TYPE, 2020–2027 (USD MILLION)
TABLE 193 REST OF ASIA PACIFIC: BIOCHEMICAL TESTS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 194 REST OF ASIA PACIFIC: URINALYSIS MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 195 REST OF ASIA PACIFIC: DISEASE SCREENING MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 196 REST OF ASIA PACIFIC: URINALYSIS MARKET, BY END USER, 2020–2027 (USD MILLION)
10.5 LATIN AMERICA
TABLE 197 LATIN AMERICA: URINALYSIS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 198 LATIN AMERICA: CONSUMABLES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 199 LATIN AMERICA: INSTRUMENTS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 200 LATIN AMERICA: AUTOMATED URINE ANALYZERS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 201 LATIN AMERICA: SEDIMENT URINE ANALYZERS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 202 LATIN AMERICA: URINALYSIS MARKET, BY TEST TYPE, 2020–2027 (USD MILLION)
TABLE 203 LATIN AMERICA: BIOCHEMICAL TESTS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 204 LATIN AMERICA: URINALYSIS MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 205 LATIN AMERICA: DISEASE SCREENING MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 206 LATIN AMERICA: URINALYSIS MARKET, BY END USER, 2020–2027 (USD MILLION)
10.5.1 RECESSION IMPACT
10.6 MIDDLE EAST & AFRICA
TABLE 207 MIDDLE EAST & AFRICA: URINALYSIS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 208 MIDDLE EAST & AFRICA: CONSUMABLES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 209 MIDDLE EAST & AFRICA: INSTRUMENTS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 210 MIDDLE EAST & AFRICA: AUTOMATED URINE ANALYZERS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 211 MIDDLE EAST & AFRICA: SEDIMENT URINE ANALYZERS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 212 MIDDLE EAST & AFRICA: URINALYSIS MARKET, BY TEST TYPE, 2020–2027 (USD MILLION)
TABLE 213 MIDDLE EAST & AFRICA: BIOCHEMICAL TESTS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 214 MIDDLE EAST & AFRICA: URINALYSIS MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 215 MIDDLE EAST & AFRICA: DISEASE SCREENING MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 216 MIDDLE EAST & AFRICA: URINALYSIS MARKET, BY END USER, 2020–2027 (USD MILLION)
10.6.1 RECESSION IMPACT
11 COMPETITIVE LANDSCAPE
11.1 OVERVIEW
11.2 STRATEGIES ADOPTED BY KEY PLAYERS/RIGHT TO WIN
11.2.1 OVERVIEW OF STRATEGIES DEPLOYED BY PLAYERS
TABLE 217 STRATEGIES DEPLOYED BY KEY COMPANIES
11.3 REVENUE SHARE ANALYSIS OF TOP MARKET PLAYERS
FIGURE 22 REVENUE SHARE ANALYSIS OF TOP PLAYERS
11.4 MARKET SHARE ANALYSIS
11.4.1 URINALYSIS MARKET
FIGURE 23 URINALYSIS MARKET SHARE, BY KEY PLAYER (2021)
TABLE 218 URINALYSIS MARKET: DEGREE OF COMPETITION
11.5 COMPANY EVALUATION QUADRANT
11.5.1 LIST OF EVALUATED VENDORS
11.5.2 STARS
11.5.3 EMERGING LEADERS
11.5.4 PERVASIVE PLAYERS
11.5.5 PARTICIPANTS
FIGURE 24 URINALYSIS MARKET: COMPETITIVE LEADERSHIP MAPPING, 2021
11.6 COMPETITIVE LEADERSHIP MAPPING FOR STARTUPS/SMES (2021)
11.6.1 PROGRESSIVE COMPANIES
11.6.2 STARTING BLOCKS
11.6.3 RESPONSIVE COMPANIES
11.6.4 DYNAMIC COMPANIES
FIGURE 25 URINALYSIS MARKET: COMPETITIVE LEADERSHIP MAPPING FOR STARTUPS/SMES, 2021
11.7 COMPETITIVE BENCHMARKING
11.7.1 PRODUCT AND GEOGRAPHIC FOOTPRINT ANALYSIS
FIGURE 26 PRODUCT AND GEOGRAPHIC FOOTPRINT ANALYSIS OF LEADING PLAYERS
TABLE 219 URINALYSIS MARKET: COMPETITIVE BENCHMARKING OF KEY PLAYERS
TABLE 220 COMPANY PRODUCT FOOTPRINT
TABLE 221 COMPANY REGIONAL FOOTPRINT
11.8 COMPETITIVE SCENARIO
11.8.1 PRODUCT LAUNCHES AND APPROVALS
TABLE 222 KEY PRODUCT LAUNCHES AND REGULATORY APPROVALS
11.8.2 DEALS
TABLE 223 KEY DEALS
12 COMPANY PROFILES
(Business Overview, Products Offered, Recent Developments, MnM View Right to win, Strategic choices made, Weaknesses and competitive threats) *
12.1 KEY PLAYERS
12.1.1 SIEMENS HEALTHINEERS AG
TABLE 224 SIEMENS HEALTHINEERS AG: BUSINESS OVERVIEW
FIGURE 27 SIEMENS HEALTHINEERS AG: COMPANY SNAPSHOT (2021)
12.1.2 F. HOFFMANN-LA ROCHE LTD.
TABLE 225 F. HOFFMANN-LA ROCHE LTD.: BUSINESS OVERVIEW
FIGURE 28 F. HOFFMANN-LA ROCHE LTD.: COMPANY SNAPSHOT (2021)
12.1.3 CARDINAL HEALTH, INC.
TABLE 226 CARDINAL HEALTH, INC.: BUSINESS OVERVIEW
FIGURE 29 CARDINAL HEALTH, INC.: COMPANY SNAPSHOT (2022)
12.1.4 ABBOTT LABORATORIES
TABLE 227 ABBOTT LABORATORIES: BUSINESS OVERVIEW
FIGURE 30 ABBOTT LABORATORIES: COMPANY SNAPSHOT (2021)
12.1.5 DANAHER CORPORATION
TABLE 228 DANAHER CORPORATION: BUSINESS OVERVIEW
FIGURE 31 DANAHER CORPORATION: COMPANY SNAPSHOT (2021)
12.1.6 SYSMEX CORPORATION
TABLE 229 SYSMEX CORPORATION: BUSINESS OVERVIEW
FIGURE 32 SYSMEX CORPORATION: COMPANY SNAPSHOT (2022)
12.1.7 THERMO FISHER SCIENTIFIC, INC.
TABLE 230 THERMO FISHER SCIENTIFIC, INC.: BUSINESS OVERVIEW
FIGURE 33 THERMO FISHER SCIENTIFIC, INC.: COMPANY SNAPSHOT (2021)
12.1.8 QUIDEL CORPORATION
TABLE 231 QUIDEL CORPORATION: BUSINESS OVERVIEW
FIGURE 34 QUIDEL CORPORATION: COMPANY SNAPSHOT (2021)
12.1.9 BECTON, DICKINSON AND COMPANY
TABLE 232 BECTON, DICKINSON AND COMPANY: BUSINESS OVERVIEW
FIGURE 35 BECTON, DICKINSON AND COMPANY: COMPANY SNAPSHOT (2021)
12.1.10 BIO-RAD LABORATORIES, INC.
TABLE 233 BIO-RAD LABORATORIES, INC.: BUSINESS OVERVIEW
FIGURE 36 BIO-RAD LABORATORIES, INC.: COMPANY SNAPSHOT (2021)
12.1.11 EKF DIAGNOSTICS
TABLE 234 EKF DIAGNOSTICS: BUSINESS OVERVIEW
FIGURE 37 EKF DIAGNOSTICS: COMPANY SNAPSHOT (2021)
12.2 OTHER PLAYERS
12.2.1 ARKRAY, INC.
TABLE 235 ARKRAY, INC.: COMPANY OVERVIEW
12.2.2 ACON LABORATORIES, INC.
TABLE 236 ACON LABORATORIES, INC.: COMPANY OVERVIEW
12.2.3 77 ELEKTRONIKA KFT.
TABLE 237 77 ELEKTRONIKA KFT.: COMPANY OVERVIEW
12.2.4 URIT MEDICAL ELECTRONIC GROUP CO., LTD.
TABLE 238 URIT MEDICAL ELECTRONIC GROUP CO., LTD.: COMPANY OVERVIEW
12.2.5 DIRUI INDUSTRIAL CO., LTD.
TABLE 239 DIRUI INDUSTRIAL CO., LTD.: COMPANY OVERVIEW
12.2.6 SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.
TABLE 240 SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.: COMPANY OVERVIEW
12.2.7 BIOBASE GROUP
TABLE 241 BIOBASE GROUP: COMPANY OVERVIEW
12.2.8 ERBA MANNHEIM
TABLE 242 ERBA MANNHEIM: COMPANY OVERVIEW
12.2.9 ALPHATEC SCIENTIFIC
TABLE 243 ALPHATEC SCIENTIFIC: COMPANY OVERVIEW
12.2.10 TECO DIAGNOSTICS
TABLE 244 TECO DIAGNOSTICS: COMPANY OVERVIEW
12.2.11 ANALYTICON BIOTECHNOLOGIES AG
TABLE 245 ANALYTICON BIOTECHNOLOGIES AG: COMPANY OVERVIEW
12.2.12 BIOWAY BIOTECHNOLOGY
TABLE 246 BIOWAY BIOTECHNOLOGY: COMPANY OVERVIEW
12.2.13 HIGH TECHNOLOGY, INC.
TABLE 247 HIGH TECHNOLOGY, INC.: COMPANY OVERVIEW
12.2.14 AGAPPE DIAGNOSTICS
TABLE 248 AGAPPE DIAGNOSTICS: COMPANY OVERVIEW
12.2.15 GENRUI BIOTECH, INC.
TABLE 249 GENRUI BIOTECH, INC.: COMPANY OVERVIEW
12.2.16 SPINREACT S.A.
TABLE 250 SPINREACT S.A.: COMPANY OVERVIEW
12.2.17 DIALAB GMBH
TABLE 251 DIALAB GMBH: COMPANY OVERVIEW
12.2.18 QUANTIMETRIX CORPORATION
TABLE 252 QUANTIMETRIX CORPORATION: COMPANY OVERVIEW
12.2.19 BIOCARE CORPORATION
TABLE 253 BIOCARE CORPORATION: COMPANY OVERVIEW
12.2.20 RANDOX LABORATORIES LTD.
TABLE 254 RANDOX LABORATORIES LTD.: COMPANY OVERVIEW
12.2.21 PZ CORMAY SA
TABLE 255 PZ CORMAY SA: COMPANY OVERVIEW
12.2.22 YD DIAGNOSTICS
TABLE 256 YD DIAGNOSTICS: COMPANY OVERVIEW
12.2.23 CONTEC MEDICAL SYSTEMS CO., LTD.
TABLE 257 CONTEC MEDICAL SYSTEMS CO., LTD.: COMPANY OVERVIEW
*Details on Business Overview, Products Offered, Recent Developments, MnM View, Right to win, Strategic choices made, Weaknesses and competitive threats might not be captured in case of unlisted companies.
13 APPENDIX
13.1 DISCUSSION GUIDE
13.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
13.3 CUSTOMIZATION OPTIONS
13.4 RELATED REPORTS
13.5 AUTHOR DETAILS
1.1 STUDY OBJECTIVES
1.2 MARKET DEFINITION
1.2.1 INCLUSIONS AND EXCLUSIONS
1.3 MARKETS COVERED
1.3.1 URINALYSIS MARKET SEGMENTATION
1.3.2 REGIONAL SCOPE
1.3.3 YEARS CONSIDERED
1.4 CURRENCY CONSIDERED
1.5 LIMITATIONS
1.6 STAKEHOLDERS
1.7 SUMMARY OF CHANGES
2 RESEARCH METHODOLOGY
2.1 RESEARCH DATA
2.2 RESEARCH APPROACH
FIGURE 1 URINALYSIS MARKET: RESEARCH DESIGN
2.2.1 SECONDARY DATA
2.2.1.1 Key data from secondary sources
2.2.1.2 Activities involved in secondary research
2.2.2 PRIMARY DATA
2.2.2.1 Primary sources
2.2.2.2 Key data from primary sources
2.2.2.3 Key industry insights
2.2.2.4 Breakdown of primary interviews
FIGURE 2 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE AND DEMAND-SIDE PARTICIPANTS
FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
2.3 MARKET SIZE ESTIMATION
2.3.1 BOTTOM-UP APPROACH
2.3.1.1 Approach 1: Company revenue estimation
FIGURE 4 BOTTOM-UP APPROACH: COMPANY REVENUE ESTIMATION APPROACH
2.3.1.2 Approach 2: Company presentations and primary interviews
2.3.1.3 CAGR projections
FIGURE 5 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS
2.3.2 TOP-DOWN APPROACH
FIGURE 6 URINALYSIS MARKET: TOP-DOWN APPROACH
2.4 DATA TRIANGULATION
FIGURE 7 DATA TRIANGULATION METHODOLOGY
2.5 MARKET SHARE ANALYSIS
2.6 STUDY ASSUMPTIONS
2.7 GROWTH RATE ASSUMPTIONS
2.8 RISK ASSESSMENT
2.8.1 RISK ASSESSMENT: URINALYSIS MARKET
2.9 RECESSION IMPACT
3 EXECUTIVE SUMMARY
FIGURE 8 URINALYSIS MARKET, BY PRODUCT, 2022 VS. 2027 (USD MILLION)
FIGURE 9 URINALYSIS MARKET, BY TEST TYPE, 2022 VS. 2027 (USD MILLION)
FIGURE 10 URINALYSIS MARKET, BY APPLICATION, 2022 VS. 2027 (USD MILLION)
FIGURE 11 URINALYSIS MARKET, BY END USER, 2022 VS. 2027 (USD MILLION)
FIGURE 12 URINALYSIS MARKET, BY REGION, 2022 VS. 2027 (USD MILLION)
4 PREMIUM INSIGHTS
4.1 URINALYSIS MARKET OVERVIEW
FIGURE 13 RISING ADOPTION OF POC DIAGNOSTICS TO SUPPORT MARKET GROWTH DURING FORECAST PERIOD
4.2 URINALYSIS MARKET SHARE, BY PRODUCT, 2022 VS. 2027
FIGURE 14 CONSUMABLES SEGMENT TO DOMINATE MARKET DURING FORECAST PERIOD
4.3 URINALYSIS MARKET SHARE, BY TEST TYPE, 2022 VS. 2027
FIGURE 15 BIOCHEMICAL URINALYSIS TO HOLD LARGEST MARKET SHARE DURING FORECAST PERIOD
4.4 URINALYSIS MARKET SHARE, BY APPLICATION, 2022 VS. 2027
FIGURE 16 DISEASE SCREENING SEGMENT TO LEAD MARKET DURING FORECAST PERIOD
4.5 URINALYSIS MARKET SHARE, BY END USER, 2022 VS. 2027
FIGURE 17 DIAGNOSTICS LABORATORIES TO ACCOUNT FOR DOMINANT MARKET SHARE DURING FORECAST PERIOD
4.6 URINALYSIS MARKET: REGIONAL GROWTH OPPORTUNITIES
FIGURE 18 ASIA PACIFIC TO REGISTER HIGHEST GROWTH RATE DURING FORECAST PERIOD
5 MARKET OVERVIEW
5.1 INTRODUCTION
5.2 MARKET DYNAMICS
FIGURE 19 URINALYSIS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
5.2.1 DRIVERS
5.2.1.1 Increasing burden of UTIs, diabetes, and liver & kidney diseases to impact market
5.2.1.2 Rising geriatric population and age-associated diseases to fuel market growth
TABLE 1 ESTIMATED INCREASE IN GERIATRIC POPULATION, BY REGION (2019–2050)
5.2.1.3 Increasing adoption of POC urine diagnostic tests to drive market
5.2.2 RESTRAINTS
5.2.2.1 Availability of refurbished urine analyzers to pose challenges for market
5.2.2.2 High capital investments and lack of skilled laboratory technicians to restrain market growth
5.2.3 OPPORTUNITIES
5.2.3.1 Increasing investments in healthcare and life sciences to fuel growth in emerging markets
5.2.3.2 Technological advancements in urine analyzers to augment market growth
5.2.3.3 Increasing government initiatives and funding for preventive care to provide growth opportunities
5.2.4 CHALLENGES
5.2.4.1 Changing regulatory landscape to challenge market growth
6 URINALYSIS MARKET, BY PRODUCT
6.1 INTRODUCTION
TABLE 2 URINALYSIS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
6.2 CONSUMABLES
TABLE 3 URINALYSIS MARKET FOR CONSUMABLES, BY TYPE, 2020–2027 (USD MILLION)
TABLE 4 URINALYSIS MARKET FOR CONSUMABLES, BY REGION, 2020–2027 (USD MILLION)
6.2.1 PREGNANCY & FERTILITY KITS
6.2.1.1 Rapid accessibility and testing convenience to drive market
TABLE 5 URINALYSIS MARKET FOR PREGNANCY & FERTILITY KITS, BY REGION, 2020–2027 (USD MILLION)
6.2.2 DIPSTICKS
6.2.2.1 Low cost and standard efficiency to increase use of dipsticks
TABLE 6 URINALYSIS MARKET FOR DIPSTICKS, BY REGION, 2020–2027 (USD MILLION)
6.2.3 DISPOSABLES
6.2.3.1 Urine collection cups to drive demand for disposables
TABLE 7 URINALYSIS MARKET FOR DISPOSABLES, BY REGION, 2020–2027 (USD MILLION)
6.2.4 REAGENTS
6.2.4.1 Increasing use of controls and calibrators to drive market growth
TABLE 8 URINALYSIS MARKET FOR REAGENTS, BY REGION, 2020–2027 (USD MILLION)
6.3 INSTRUMENTS
TABLE 9 KEY PRODUCTS IN INSTRUMENTS SEGMENT
TABLE 10 URINALYSIS MARKET FOR INSTRUMENTS, BY TYPE, 2020–2027 (USD MILLION)
TABLE 11 URINALYSIS MARKET FOR INSTRUMENTS, BY REGION, 2020–2027 (USD MILLION)
6.3.1 AUTOMATED URINE ANALYZERS
TABLE 12 URINALYSIS MARKET FOR AUTOMATED URINE ANALYZERS, BY TYPE, 2020–2027 (USD MILLION)
TABLE 13 URINALYSIS MARKET FOR AUTOMATED URINE ANALYZERS, BY REGION, 2020–2027 (USD MILLION)
6.3.1.1 Integrated urine analyzers
6.3.1.1.1 Higher workload in hospitals and laboratories to increase adoption of integrated urine analyzers
TABLE 14 URINALYSIS MARKET FOR INTEGRATED URINE ANALYZERS, BY REGION, 2020–2027 (USD MILLION)
6.3.1.2 Sediment urine analyzers
TABLE 15 URINALYSIS MARKET FOR SEDIMENT URINE ANALYZERS, BY TYPE, 2020–2027 (USD MILLION)
TABLE 16 URINALYSIS MARKET FOR SEDIMENT URINE ANALYZERS, BY REGION, 2020–2027 (USD MILLION)
6.3.1.2.1 Microscopy analyzers
6.3.1.2.1.1 Increased adoption of automated microscopy urine analyzers to drive market growth
TABLE 17 URINALYSIS MARKET FOR MICROSCOPY ANALYZERS, BY REGION, 2020–2027 (USD MILLION)
6.3.1.2.2 Flow cytometry analyzers
6.3.1.2.2.1 Accuracy and sensitivity of flow cytometry analyzers to drive adoption
TABLE 18 URINALYSIS MARKET FOR FLOW CYTOMETRY ANALYZERS, BY REGION, 2020–2027 (USD MILLION)
6.3.1.3 Biochemical urine analyzers
6.3.1.3.1 Increasing incidence of kidney diseases and UTIs to drive market
TABLE 19 URINALYSIS MARKET FOR BIOCHEMICAL URINE ANALYZERS, BY REGION, 2020–2027 (USD MILLION)
6.3.2 SEMI-AUTOMATED URINE ANALYZERS
6.3.2.1 Extensive use of semi-automated urine analyzers in hospitals & clinics to drive segment growth
TABLE 20 URINALYSIS MARKET FOR SEMI-AUTOMATED URINE ANALYZERS, BY REGION, 2020–2027 (USD MILLION)
6.3.3 POINT-OF-CARE URINE ANALYZERS
6.3.3.1 Need for rapid testing to drive demand for POC urine analyzers
TABLE 21 URINALYSIS MARKET FOR POC URINE ANALYZERS, BY REGION, 2020–2027 (USD MILLION)
7 URINALYSIS MARKET, BY TEST TYPE
7.1 INTRODUCTION
TABLE 22 URINALYSIS MARKET, BY TEST TYPE, 2020–2027 (USD MILLION)
7.2 PREGNANCY & FERTILITY TESTS
7.2.1 RISING DEMAND FOR RAPID SELF-CONTAINED TESTS TO DRIVE SEGMENT GROWTH
TABLE 23 URINALYSIS MARKET FOR PREGNANCY & FERTILITY TESTS, BY REGION, 2020–2027 (USD MILLION)
7.3 BIOCHEMICAL TESTS
TABLE 24 URINALYSIS MARKET FOR BIOCHEMICAL TESTS, BY TYPE, 2020–2027 (USD MILLION)
TABLE 25 URINALYSIS MARKET FOR BIOCHEMICAL TESTS, BY REGION, 2020–2027 (USD MILLION)
7.3.1 LABORATORY TESTS
7.3.1.1 Growing incidence of UTIs and other kidney diseases to drive market
TABLE 26 URINALYSIS MARKET FOR LABORATORY TESTS, BY REGION, 2020–2027 (USD MILLION)
7.3.2 POC TESTS
7.3.2.1 Convenience of POC testing to drive segment growth
TABLE 27 URINALYSIS MARKET FOR POC TESTS, BY REGION, 2020–2027 (USD MILLION)
7.4 SEDIMENT URINALYSIS
7.4.1 INCREASED ADOPTION OF AUTOMATED ANALYZERS TO DRIVE MARKET GROWTH
TABLE 28 URINALYSIS MARKET FOR SEDIMENT URINALYSIS, BY TYPE, 2020–2027 (USD MILLION)
8 URINALYSIS MARKET, BY APPLICATION
8.1 INTRODUCTION
TABLE 29 URINALYSIS MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
8.2 DISEASE SCREENING
TABLE 30 URINALYSIS MARKET FOR DISEASE SCREENING, BY TYPE, 2020–2027 (USD MILLION)
TABLE 31 URINALYSIS MARKET FOR DISEASE SCREENING, BY REGION, 2020–2027 (USD MILLION)
8.2.1 URINARY TRACT INFECTIONS
8.2.1.1 Increasing prevalence of UTIs to drive segment growth
TABLE 32 URINALYSIS MARKET FOR URINARY TRACT INFECTIONS, BY REGION, 2020–2027 (USD MILLION)
8.2.2 KIDNEY DISEASES
8.2.2.1 Rapidly growing geriatric population and prevalence of kidney diseases to fuel segment growth
TABLE 33 URINALYSIS MARKET FOR KIDNEY DISEASES, BY REGION, 2020–2027 (USD MILLION)
8.2.3 DIABETES
8.2.3.1 Development of advanced analytical tools for diabetes to drive market growth
TABLE 34 URINALYSIS MARKET FOR DIABETES, BY REGION, 2020–2027 (USD MILLION)
8.2.4 LIVER DISEASES
8.2.4.1 High prevalence of liver diseases to fuel segment growth
TABLE 35 URINALYSIS MARKET FOR LIVER DISEASES, BY REGION, 2020–2027 (USD MILLION)
8.2.5 OTHER DISEASE SCREENING APPLICATIONS
TABLE 36 URINALYSIS MARKET FOR OTHER DISEASE SCREENING APPLICATIONS, BY REGION, 2020–2027 (USD MILLION)
8.3 PREGNANCY & FERTILITY
8.3.1 NEED FOR EARLY DETECTION OF PREGNANCY TO DRIVE SEGMENT
TABLE 37 URINALYSIS MARKET FOR PREGNANCY & FERTILITY, BY REGION, 2020–2027 (USD MILLION)
9 URINALYSIS MARKET, BY END USER
9.1 INTRODUCTION
TABLE 38 URINALYSIS MARKET, BY END USER, 2020–2027 (USD MILLION)
9.2 DIAGNOSTIC LABORATORIES
9.2.1 INCREASED OUTSOURCING OF DIAGNOSTIC TESTS BY HOSPITALS TO LABORATORIES TO AUGMENT MARKET
TABLE 39 URINALYSIS MARKET FOR DIAGNOSTIC LABORATORIES, BY REGION, 2020–2027 (USD MILLION)
9.3 HOSPITALS & CLINICS
9.3.1 INCREASING ADOPTION OF DIAGNOSTIC TOOLS FOR URINALYSIS TESTING TO DRIVE MARKET
TABLE 40 URINALYSIS MARKET FOR HOSPITALS & CLINICS, BY REGION, 2020–2027 (USD MILLION)
9.4 HOME CARE SETTINGS
9.4.1 INCREASING PREFERENCE FOR RAPID TESTING AND CONVENIENCE TO BOOST MARKET
TABLE 41 URINALYSIS MARKET FOR HOME CARE SETTINGS, BY REGION, 2020–2027 (USD MILLION)
9.5 RESEARCH LABORATORIES & INSTITUTES
9.5.1 DEVELOPING INNOVATIVE TESTS FOR DISEASE DETECTION TO FUEL MARKET
TABLE 42 URINALYSIS MARKET FOR RESEARCH LABORATORIES & INSTITUTES, BY REGION, 2020–2027 (USD MILLION)
10 URINALYSIS MARKET, BY REGION
10.1 INTRODUCTION
TABLE 43 URINALYSIS MARKET, BY REGION, 2020–2027 (USD MILLION)
10.2 NORTH AMERICA
FIGURE 20 NORTH AMERICA: URINALYSIS MARKET SNAPSHOT
TABLE 44 NORTH AMERICA: URINALYSIS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 45 NORTH AMERICA: URINALYSIS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 46 NORTH AMERICA: CONSUMABLES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 47 NORTH AMERICA: INSTRUMENTS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 48 NORTH AMERICA: AUTOMATED URINE ANALYZERS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 49 NORTH AMERICA: SEDIMENT URINE ANALYZERS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 50 NORTH AMERICA: URINALYSIS MARKET, BY TEST TYPE, 2020–2027 (USD MILLION)
TABLE 51 NORTH AMERICA: BIOCHEMICAL TESTS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 52 NORTH AMERICA: URINALYSIS MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 53 NORTH AMERICA: DISEASE SCREENING MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 54 NORTH AMERICA: URINALYSIS MARKET, BY END USER, 2020–2027 (USD MILLION)
10.2.1 RECESSION IMPACT
10.2.2 US
10.2.2.1 Rapid growth of geriatric population to drive market growth
TABLE 55 US: URINALYSIS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 56 US: CONSUMABLES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 57 US: INSTRUMENTS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 58 US: AUTOMATED URINE ANALYZERS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 59 US: SEDIMENT URINE ANALYZERS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 60 US: URINALYSIS MARKET, BY TEST TYPE, 2020–2027 (USD MILLION)
TABLE 61 US: BIOCHEMICAL TESTS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 62 US: URINALYSIS MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 63 US: DISEASE SCREENING MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 64 US: URINALYSIS MARKET, BY END USER, 2020–2027 (USD MILLION)
10.2.3 CANADA
10.2.3.1 Increasing prevalence of chronic diseases to augment market
TABLE 65 CANADA: URINALYSIS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 66 CANADA: CONSUMABLES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 67 CANADA: INSTRUMENTS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 68 CANADA: AUTOMATED URINE ANALYZERS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 69 CANADA: SEDIMENT URINE ANALYZERS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 70 CANADA: URINALYSIS MARKET, BY TEST TYPE, 2020–2027 (USD MILLION)
TABLE 71 CANADA: BIOCHEMICAL TESTS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 72 CANADA: URINALYSIS MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 73 CANADA: DISEASE SCREENING MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 74 CANADA: URINALYSIS MARKET, BY END USER, 2020–2027 (USD MILLION)
10.3 EUROPE
TABLE 75 EUROPE: URINALYSIS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 76 EUROPE: URINALYSIS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 77 EUROPE: CONSUMABLES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 78 EUROPE: INSTRUMENTS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 79 EUROPE: AUTOMATED URINE ANALYZERS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 80 EUROPE: SEDIMENT URINE ANALYZERS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 81 EUROPE: URINALYSIS MARKET, BY TEST TYPE, 2020–2027 (USD MILLION)
TABLE 82 EUROPE: BIOCHEMICAL TESTS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 83 EUROPE: URINALYSIS MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 84 EUROPE: DISEASE SCREENING MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 85 EUROPE: URINALYSIS MARKET, BY END USER, 2020–2027 (USD MILLION)
10.3.1 RECESSION IMPACT
10.3.2 GERMANY
10.3.2.1 Increasing healthcare expenditure to fuel market growth
TABLE 86 GERMANY: URINALYSIS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 87 GERMANY: CONSUMABLES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 88 GERMANY: INSTRUMENTS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 89 GERMANY: AUTOMATED URINE ANALYZERS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 90 GERMANY: SEDIMENT URINE ANALYZERS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 91 GERMANY: URINALYSIS MARKET, BY TEST TYPE, 2020–2027 (USD MILLION)
TABLE 92 GERMANY: BIOCHEMICAL TESTS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 93 GERMANY: URINALYSIS MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 94 GERMANY: DISEASE SCREENING MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 95 GERMANY: URINALYSIS MARKET, BY END USER, 2020–2027 (USD MILLION)
10.3.3 UK
10.3.3.1 Rising government healthcare expenditure to propel market growth
TABLE 96 UK: URINALYSIS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 97 UK: CONSUMABLES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 98 UK: INSTRUMENTS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 99 UK: AUTOMATED URINE ANALYZERS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 100 UK: SEDIMENT URINE ANALYZERS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 101 UK: URINALYSIS MARKET, BY TEST TYPE, 2020–2027 (USD MILLION)
TABLE 102 UK: BIOCHEMICAL TESTS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 103 UK: URINALYSIS MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 104 UK: DISEASE SCREENING MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 105 UK: URINALYSIS MARKET, BY END USER, 2020–2027 (USD MILLION)
10.3.4 FRANCE
10.3.4.1 High R&D expenditure to provide growth opportunities
TABLE 106 FRANCE: URINALYSIS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 107 FRANCE: CONSUMABLES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 108 FRANCE: INSTRUMENTS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 109 FRANCE: AUTOMATED URINE ANALYZERS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 110 FRANCE: SEDIMENT URINE ANALYZERS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 111 FRANCE: URINALYSIS MARKET, BY TEST TYPE, 2020–2027 (USD MILLION)
TABLE 112 FRANCE: BIOCHEMICAL TESTS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 113 FRANCE: URINALYSIS MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 114 FRANCE: DISEASE SCREENING MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 115 FRANCE: URINALYSIS MARKET, BY END USER, 2020–2027 (USD MILLION)
10.3.5 ITALY
10.3.5.1 Large aging population to drive market growth
TABLE 116 ITALY: URINALYSIS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 117 ITALY: CONSUMABLES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 118 ITALY: INSTRUMENTS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 119 ITALY: AUTOMATED URINE ANALYZERS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 120 ITALY: SEDIMENT URINE ANALYZERS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 121 ITALY: URINALYSIS MARKET, BY TEST TYPE, 2020–2027 (USD MILLION)
TABLE 122 ITALY: BIOCHEMICAL TESTS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 123 ITALY: URINALYSIS MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 124 ITALY: DISEASE SCREENING MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 125 ITALY: URINALYSIS MARKET, BY END USER, 2020–2027 (USD MILLION)
10.3.6 SPAIN
10.3.6.1 Rising geriatric population to propel market
TABLE 126 SPAIN: URINALYSIS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 127 SPAIN: CONSUMABLES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 128 SPAIN: INSTRUMENTS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 129 SPAIN: AUTOMATED URINE ANALYZERS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 130 SPAIN: SEDIMENT URINE ANALYZERS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 131 SPAIN: URINALYSIS MARKET, BY TEST TYPE, 2020–2027 (USD MILLION)
TABLE 132 SPAIN: BIOCHEMICAL TESTS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 133 SPAIN: URINALYSIS MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 134 SPAIN: DISEASE SCREENING MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 135 SPAIN: URINALYSIS MARKET, BY END USER, 2020–2027 (USD MILLION)
10.3.7 REST OF EUROPE
TABLE 136 REST OF EUROPE: URINALYSIS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 137 REST OF EUROPE: CONSUMABLES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 138 REST OF EUROPE: INSTRUMENTS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 139 REST OF EUROPE: AUTOMATED URINE ANALYZERS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 140 REST OF EUROPE: SEDIMENT URINE ANALYZERS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 141 REST OF EUROPE: URINALYSIS MARKET, BY TEST TYPE, 2020–2027 (USD MILLION)
TABLE 142 REST OF EUROPE: BIOCHEMICAL TESTS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 143 REST OF EUROPE: URINALYSIS MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 144 REST OF EUROPE: DISEASE SCREENING MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 145 REST OF EUROPE: URINALYSIS MARKET, BY END USER, 2020–2027 (USD MILLION)
10.4 ASIA PACIFIC
FIGURE 21 ASIA PACIFIC: URINALYSIS MARKET SNAPSHOT
TABLE 146 ASIA PACIFIC: URINALYSIS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 147 ASIA PACIFIC: URINALYSIS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 148 ASIA PACIFIC: CONSUMABLES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 149 ASIA PACIFIC: INSTRUMENTS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 150 ASIA PACIFIC: AUTOMATED URINE ANALYZERS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 151 ASIA PACIFIC: SEDIMENT URINE ANALYZERS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 152 ASIA PACIFIC: URINALYSIS MARKET, BY TEST TYPE, 2020–2027 (USD MILLION)
TABLE 153 ASIA PACIFIC: BIOCHEMICAL TESTS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 154 ASIA PACIFIC: URINALYSIS MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 155 ASIA PACIFIC: DISEASE SCREENING MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 156 ASIA PACIFIC: URINALYSIS MARKET, BY END USER, 2020–2027 (USD MILLION)
10.4.1 RECESSION IMPACT
10.4.2 CHINA
10.4.2.1 Improving healthcare infrastructure in China to support market growth
TABLE 157 CHINA: URINALYSIS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 158 CHINA: CONSUMABLES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 159 CHINA: INSTRUMENTS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 160 CHINA: AUTOMATED URINE ANALYZERS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 161 CHINA: SEDIMENT URINE ANALYZERS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 162 CHINA: URINALYSIS MARKET, BY TEST TYPE, 2020–2027 (USD MILLION)
TABLE 163 CHINA: BIOCHEMICAL TESTS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 164 CHINA: URINALYSIS MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 165 CHINA: DISEASE SCREENING MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 166 CHINA: URINALYSIS MARKET, BY END USER, 2020–2027 (USD MILLION)
10.4.3 JAPAN
10.4.3.1 Favorable regulatory framework to drive market growth
TABLE 167 JAPAN: URINALYSIS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 168 JAPAN: CONSUMABLES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 169 JAPAN: INSTRUMENTS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 170 JAPAN: AUTOMATED URINE ANALYZERS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 171 JAPAN: SEDIMENT URINE ANALYZERS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 172 JAPAN: URINALYSIS MARKET, BY TEST TYPE, 2020–2027 (USD MILLION)
TABLE 173 JAPAN: BIOCHEMICAL TESTS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 174 JAPAN: URINALYSIS MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 175 JAPAN: DISEASE SCREENING MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 176 JAPAN: URINALYSIS MARKET, BY END USER, 2020–2027 (USD MILLION)
10.4.4 INDIA
10.4.4.1 Increasing investment in India’s healthcare system to drive market
TABLE 177 INDIA: URINALYSIS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 178 INDIA: CONSUMABLES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 179 INDIA: INSTRUMENTS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 180 INDIA: AUTOMATED URINE ANALYZERS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 181 INDIA: SEDIMENT URINE ANALYZERS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 182 INDIA: URINALYSIS MARKET, BY TEST TYPE, 2020–2027 (USD MILLION)
TABLE 183 INDIA: BIOCHEMICAL TESTS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 184 INDIA: URINALYSIS MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 185 INDIA: DISEASE SCREENING MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 186 INDIA: URINALYSIS MARKET, BY END USER, 2020–2027 (USD MILLION)
10.4.5 REST OF ASIA PACIFIC
TABLE 187 REST OF ASIA PACIFIC: URINALYSIS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 188 REST OF ASIA PACIFIC: CONSUMABLES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 189 REST OF ASIA PACIFIC: INSTRUMENTS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 190 REST OF ASIA PACIFIC: AUTOMATED URINE ANALYZERS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 191 REST OF ASIA PACIFIC: SEDIMENT URINE ANALYZERS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 192 REST OF ASIA PACIFIC: URINALYSIS MARKET, BY TEST TYPE, 2020–2027 (USD MILLION)
TABLE 193 REST OF ASIA PACIFIC: BIOCHEMICAL TESTS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 194 REST OF ASIA PACIFIC: URINALYSIS MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 195 REST OF ASIA PACIFIC: DISEASE SCREENING MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 196 REST OF ASIA PACIFIC: URINALYSIS MARKET, BY END USER, 2020–2027 (USD MILLION)
10.5 LATIN AMERICA
TABLE 197 LATIN AMERICA: URINALYSIS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 198 LATIN AMERICA: CONSUMABLES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 199 LATIN AMERICA: INSTRUMENTS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 200 LATIN AMERICA: AUTOMATED URINE ANALYZERS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 201 LATIN AMERICA: SEDIMENT URINE ANALYZERS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 202 LATIN AMERICA: URINALYSIS MARKET, BY TEST TYPE, 2020–2027 (USD MILLION)
TABLE 203 LATIN AMERICA: BIOCHEMICAL TESTS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 204 LATIN AMERICA: URINALYSIS MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 205 LATIN AMERICA: DISEASE SCREENING MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 206 LATIN AMERICA: URINALYSIS MARKET, BY END USER, 2020–2027 (USD MILLION)
10.5.1 RECESSION IMPACT
10.6 MIDDLE EAST & AFRICA
TABLE 207 MIDDLE EAST & AFRICA: URINALYSIS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 208 MIDDLE EAST & AFRICA: CONSUMABLES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 209 MIDDLE EAST & AFRICA: INSTRUMENTS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 210 MIDDLE EAST & AFRICA: AUTOMATED URINE ANALYZERS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 211 MIDDLE EAST & AFRICA: SEDIMENT URINE ANALYZERS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 212 MIDDLE EAST & AFRICA: URINALYSIS MARKET, BY TEST TYPE, 2020–2027 (USD MILLION)
TABLE 213 MIDDLE EAST & AFRICA: BIOCHEMICAL TESTS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 214 MIDDLE EAST & AFRICA: URINALYSIS MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 215 MIDDLE EAST & AFRICA: DISEASE SCREENING MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 216 MIDDLE EAST & AFRICA: URINALYSIS MARKET, BY END USER, 2020–2027 (USD MILLION)
10.6.1 RECESSION IMPACT
11 COMPETITIVE LANDSCAPE
11.1 OVERVIEW
11.2 STRATEGIES ADOPTED BY KEY PLAYERS/RIGHT TO WIN
11.2.1 OVERVIEW OF STRATEGIES DEPLOYED BY PLAYERS
TABLE 217 STRATEGIES DEPLOYED BY KEY COMPANIES
11.3 REVENUE SHARE ANALYSIS OF TOP MARKET PLAYERS
FIGURE 22 REVENUE SHARE ANALYSIS OF TOP PLAYERS
11.4 MARKET SHARE ANALYSIS
11.4.1 URINALYSIS MARKET
FIGURE 23 URINALYSIS MARKET SHARE, BY KEY PLAYER (2021)
TABLE 218 URINALYSIS MARKET: DEGREE OF COMPETITION
11.5 COMPANY EVALUATION QUADRANT
11.5.1 LIST OF EVALUATED VENDORS
11.5.2 STARS
11.5.3 EMERGING LEADERS
11.5.4 PERVASIVE PLAYERS
11.5.5 PARTICIPANTS
FIGURE 24 URINALYSIS MARKET: COMPETITIVE LEADERSHIP MAPPING, 2021
11.6 COMPETITIVE LEADERSHIP MAPPING FOR STARTUPS/SMES (2021)
11.6.1 PROGRESSIVE COMPANIES
11.6.2 STARTING BLOCKS
11.6.3 RESPONSIVE COMPANIES
11.6.4 DYNAMIC COMPANIES
FIGURE 25 URINALYSIS MARKET: COMPETITIVE LEADERSHIP MAPPING FOR STARTUPS/SMES, 2021
11.7 COMPETITIVE BENCHMARKING
11.7.1 PRODUCT AND GEOGRAPHIC FOOTPRINT ANALYSIS
FIGURE 26 PRODUCT AND GEOGRAPHIC FOOTPRINT ANALYSIS OF LEADING PLAYERS
TABLE 219 URINALYSIS MARKET: COMPETITIVE BENCHMARKING OF KEY PLAYERS
TABLE 220 COMPANY PRODUCT FOOTPRINT
TABLE 221 COMPANY REGIONAL FOOTPRINT
11.8 COMPETITIVE SCENARIO
11.8.1 PRODUCT LAUNCHES AND APPROVALS
TABLE 222 KEY PRODUCT LAUNCHES AND REGULATORY APPROVALS
11.8.2 DEALS
TABLE 223 KEY DEALS
12 COMPANY PROFILES
(Business Overview, Products Offered, Recent Developments, MnM View Right to win, Strategic choices made, Weaknesses and competitive threats) *
12.1 KEY PLAYERS
12.1.1 SIEMENS HEALTHINEERS AG
TABLE 224 SIEMENS HEALTHINEERS AG: BUSINESS OVERVIEW
FIGURE 27 SIEMENS HEALTHINEERS AG: COMPANY SNAPSHOT (2021)
12.1.2 F. HOFFMANN-LA ROCHE LTD.
TABLE 225 F. HOFFMANN-LA ROCHE LTD.: BUSINESS OVERVIEW
FIGURE 28 F. HOFFMANN-LA ROCHE LTD.: COMPANY SNAPSHOT (2021)
12.1.3 CARDINAL HEALTH, INC.
TABLE 226 CARDINAL HEALTH, INC.: BUSINESS OVERVIEW
FIGURE 29 CARDINAL HEALTH, INC.: COMPANY SNAPSHOT (2022)
12.1.4 ABBOTT LABORATORIES
TABLE 227 ABBOTT LABORATORIES: BUSINESS OVERVIEW
FIGURE 30 ABBOTT LABORATORIES: COMPANY SNAPSHOT (2021)
12.1.5 DANAHER CORPORATION
TABLE 228 DANAHER CORPORATION: BUSINESS OVERVIEW
FIGURE 31 DANAHER CORPORATION: COMPANY SNAPSHOT (2021)
12.1.6 SYSMEX CORPORATION
TABLE 229 SYSMEX CORPORATION: BUSINESS OVERVIEW
FIGURE 32 SYSMEX CORPORATION: COMPANY SNAPSHOT (2022)
12.1.7 THERMO FISHER SCIENTIFIC, INC.
TABLE 230 THERMO FISHER SCIENTIFIC, INC.: BUSINESS OVERVIEW
FIGURE 33 THERMO FISHER SCIENTIFIC, INC.: COMPANY SNAPSHOT (2021)
12.1.8 QUIDEL CORPORATION
TABLE 231 QUIDEL CORPORATION: BUSINESS OVERVIEW
FIGURE 34 QUIDEL CORPORATION: COMPANY SNAPSHOT (2021)
12.1.9 BECTON, DICKINSON AND COMPANY
TABLE 232 BECTON, DICKINSON AND COMPANY: BUSINESS OVERVIEW
FIGURE 35 BECTON, DICKINSON AND COMPANY: COMPANY SNAPSHOT (2021)
12.1.10 BIO-RAD LABORATORIES, INC.
TABLE 233 BIO-RAD LABORATORIES, INC.: BUSINESS OVERVIEW
FIGURE 36 BIO-RAD LABORATORIES, INC.: COMPANY SNAPSHOT (2021)
12.1.11 EKF DIAGNOSTICS
TABLE 234 EKF DIAGNOSTICS: BUSINESS OVERVIEW
FIGURE 37 EKF DIAGNOSTICS: COMPANY SNAPSHOT (2021)
12.2 OTHER PLAYERS
12.2.1 ARKRAY, INC.
TABLE 235 ARKRAY, INC.: COMPANY OVERVIEW
12.2.2 ACON LABORATORIES, INC.
TABLE 236 ACON LABORATORIES, INC.: COMPANY OVERVIEW
12.2.3 77 ELEKTRONIKA KFT.
TABLE 237 77 ELEKTRONIKA KFT.: COMPANY OVERVIEW
12.2.4 URIT MEDICAL ELECTRONIC GROUP CO., LTD.
TABLE 238 URIT MEDICAL ELECTRONIC GROUP CO., LTD.: COMPANY OVERVIEW
12.2.5 DIRUI INDUSTRIAL CO., LTD.
TABLE 239 DIRUI INDUSTRIAL CO., LTD.: COMPANY OVERVIEW
12.2.6 SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.
TABLE 240 SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.: COMPANY OVERVIEW
12.2.7 BIOBASE GROUP
TABLE 241 BIOBASE GROUP: COMPANY OVERVIEW
12.2.8 ERBA MANNHEIM
TABLE 242 ERBA MANNHEIM: COMPANY OVERVIEW
12.2.9 ALPHATEC SCIENTIFIC
TABLE 243 ALPHATEC SCIENTIFIC: COMPANY OVERVIEW
12.2.10 TECO DIAGNOSTICS
TABLE 244 TECO DIAGNOSTICS: COMPANY OVERVIEW
12.2.11 ANALYTICON BIOTECHNOLOGIES AG
TABLE 245 ANALYTICON BIOTECHNOLOGIES AG: COMPANY OVERVIEW
12.2.12 BIOWAY BIOTECHNOLOGY
TABLE 246 BIOWAY BIOTECHNOLOGY: COMPANY OVERVIEW
12.2.13 HIGH TECHNOLOGY, INC.
TABLE 247 HIGH TECHNOLOGY, INC.: COMPANY OVERVIEW
12.2.14 AGAPPE DIAGNOSTICS
TABLE 248 AGAPPE DIAGNOSTICS: COMPANY OVERVIEW
12.2.15 GENRUI BIOTECH, INC.
TABLE 249 GENRUI BIOTECH, INC.: COMPANY OVERVIEW
12.2.16 SPINREACT S.A.
TABLE 250 SPINREACT S.A.: COMPANY OVERVIEW
12.2.17 DIALAB GMBH
TABLE 251 DIALAB GMBH: COMPANY OVERVIEW
12.2.18 QUANTIMETRIX CORPORATION
TABLE 252 QUANTIMETRIX CORPORATION: COMPANY OVERVIEW
12.2.19 BIOCARE CORPORATION
TABLE 253 BIOCARE CORPORATION: COMPANY OVERVIEW
12.2.20 RANDOX LABORATORIES LTD.
TABLE 254 RANDOX LABORATORIES LTD.: COMPANY OVERVIEW
12.2.21 PZ CORMAY SA
TABLE 255 PZ CORMAY SA: COMPANY OVERVIEW
12.2.22 YD DIAGNOSTICS
TABLE 256 YD DIAGNOSTICS: COMPANY OVERVIEW
12.2.23 CONTEC MEDICAL SYSTEMS CO., LTD.
TABLE 257 CONTEC MEDICAL SYSTEMS CO., LTD.: COMPANY OVERVIEW
*Details on Business Overview, Products Offered, Recent Developments, MnM View, Right to win, Strategic choices made, Weaknesses and competitive threats might not be captured in case of unlisted companies.
13 APPENDIX
13.1 DISCUSSION GUIDE
13.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
13.3 CUSTOMIZATION OPTIONS
13.4 RELATED REPORTS
13.5 AUTHOR DETAILS
The global urinalysis market is expected to reach $1.28 billion by 2019 from $0.89 billion in 2014, growing at a CAGR of 7.6% from 2014 to 2019.
Key players in the urinalysis market include Alere Inc. (Acon Labs) (U.S.), ARKRAY Inc. (Japan), Bio-Rad (U.S.), Danaher (Iris International) (U.S.), E77 Eletronika (Hungary), Mindray (China), Roche Diagnostics (Switzerland), Siemens Healthcare (Germany), Sysmex (Japan), and Urit Medical (China) amongst others
The report segments this market on the basis of products, test type, applications, end user, and geography. In the test type market, the biochemical urinalysis segment is expected to account for the largest share in 2014. The biochemical urinalysis is a cost effective and accurate method for diagnosing various types of diseases; this is a major reason for the high growth of this market. The sediment urinalysis segment is expected to grow at the highest CAGR from 2014 to 2019, due to the technological advancements and launch of new and advanced products in the market.
Based on geography, the global urinalysis market is dominated by North America, followed by Europe, Asia, and the Rest of the World (RoW). North America is expected to account for the largest share of the market by the end of 2014. The growth of this market is driven by factors such as increasing number of prognostic urinalysis tests, implementation of affordable care act in the U.S., and rising incidences of diabetes in the region.
